Skip to content

Advertisement

  • Poster presentation
  • Open Access

Point prevalence, lab-based survey of antimicrobial resistance in referral and regional hospitals in Oman

  • 1,
  • 1 and
  • 1
Antimicrobial Resistance and Infection Control20154 (Suppl 1) :P128

https://doi.org/10.1186/2047-2994-4-S1-P128

  • Published:

Keywords

  • Staphylococcus Aureus
  • Antimicrobial Resistance
  • Klebsiella Pneumoniae
  • Regional Hospital
  • Prevalence Survey

Introduction

Anti-Microbial Resistance (AMR) is both a clinical challenge and a public health threat as AMR infection worsens patient clinical outcome and burden of health systems. Cost of treatment, lengths of hospital stays, and morbidity and mortality increased. Few studies have described the prevalence of antimicrobial resistance in Oman, but those studies are limited to either one hospital or one organism.

Objectives

This study aims to assess the prevalence of antimicrobial resistance among the tertiary and secondary care governmental hospitals in Oman.

Methods

This is a point-prevalence survey using the World Health Organization (WHO) tool [1] conducted 16-22 March 2014. 11/15 (73.3%) of the referral and regional hospitals of the country participated. Microsoft Excel used to collect data on five AMR organisms; Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococci (VRE), Extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae (CRE), and Multi-Resistant Acinetobacter spp (MRAB). SSPS software used to describe the overall results.

Results

254 bacterial isolates have been identified. 90 (35.4%) are Gram positive {Staphylococcus aureus (13 isolates, 14.4%), Enterococci spp (11, 12.2%) and others (66, 73.3%)}, while 164 (64.6%) are Gram negative {Enterobacteriaceae spp. (120 isolates, 73.2%), Acinetobacter spp. (10, 6.1%), and others (34, 20.7%)}. 47/254 (18.5%) isolates have AMR feature (either MRSA, VRE, ESBL, CRE or MRAB). 6 (60%) are MRAB out of the 10 total Acinetobacter isolates. Among the 73 isolates of E. coli, 24 (32.9%) isolates are ESBL while no CRE identified. 10 (27%) ESBL isolates recognized among the 37 Klebsiella pneumoniae and 2 (5.4%) are CRE. 4 MRSA isolates (30.8%) identified among the Staphylococcus aureus. One sample (9%) is VRE among the Enterococci spp.

Conclusion

The prevalence of resistance is higher in Acinetobacter, E.coli, MRSA, Klebsiella, and Enterococci respectively. This study is the first prevalence survey that covers multiple organisms and many hospitals in Oman and provides important baseline. Capacities are available in the participating hospitals to identify AMR organisms. Continual and national surveillance is the optimal goal for the accurate and generalized data on AMR.

Disclosure of interest

None declared.

Authors’ Affiliations

(1)
Infection Prevention & Control Department, Ministry of Health, Oman, Muscat, Oman

Copyright

© Zayed et al; licensee BioMed Central Ltd. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement